| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models
|
Benavent Acero, Fernando
|
|
2017
|
107 |
C |
p. 14-21
8 p.
|
artikel
|
| 2 |
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients
|
Sorber, L.
|
|
2017
|
107 |
C |
p. 100-107
8 p.
|
artikel
|
| 3 |
Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy
|
Tomasetti, Marco
|
|
2017
|
107 |
C |
p. 65-72
8 p.
|
artikel
|
| 4 |
Contents
|
|
|
2017
|
107 |
C |
p. iv-
1 p.
|
artikel
|
| 5 |
Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing
|
Doble, Brett
|
|
2017
|
107 |
C |
p. 22-35
14 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2017
|
107 |
C |
p. iii-
1 p.
|
artikel
|
| 7 |
Integration of multiple “OMIC” biomarkers: A precision medicine strategy for lung cancer
|
Robles, Ana I.
|
|
2017
|
107 |
C |
p. 50-58
9 p.
|
artikel
|
| 8 |
MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors
|
Rothschild, Sacha I.
|
|
2017
|
107 |
C |
p. 73-83
11 p.
|
artikel
|
| 9 |
O6-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
|
Hiddinga, Birgitta I.
|
|
2017
|
107 |
C |
p. 91-99
9 p.
|
artikel
|
| 10 |
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
|
Bahce, I.
|
|
2017
|
107 |
C |
p. 1-13
13 p.
|
artikel
|
| 11 |
Possible applications of circulating tumor cells in patients with non small cell lung cancer
|
Tartarone, Alfredo
|
|
2017
|
107 |
C |
p. 59-64
6 p.
|
artikel
|
| 12 |
Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients
|
Lievense, Lysanne A.
|
|
2017
|
107 |
C |
p. 36-40
5 p.
|
artikel
|
| 13 |
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice—A new approach to improve personalized translational research
|
Vavalà, Tiziana
|
|
2017
|
107 |
C |
p. 84-90
7 p.
|
artikel
|
| 14 |
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs
|
Malapelle, Umberto
|
|
2017
|
107 |
C |
p. 41-49
9 p.
|
artikel
|
Tijdschrift beschrijving